Flyte Aviation subsidiary Catheter Precision gains FDA clearance for broader VIVO use
VJET•Catheter Precision, a wholly owned subsidiary of Flyte Aviation, received FDA 510(k) clearance to use its VIVO system in patients with structural heart disease undergoing catheter ablation for monomorphic ventricular tachycardia.
1. Expanded FDA clearance
Catheter Precision received FDA 510(k) clearance for expanded use of its VIVO system. The clearance covers patients with structural heart disease undergoing catheter ablation for monomorphic ventricular tachycardia.
